OBJECTIVES: Quantitative magnetic resonance imaging (MRI) can potentially meet the pressing need for objective, sensitive, reproducible outcome measures in neuromuscular disease trials. We tested, in healthy volunteers, the consistency, reliability and sensitivity to normal inter-subject variation of MRI methods targeted to lower limb muscle pathology to inform the design of practical but comprehensive MRI outcome measure protocols for use in imminent patient studies. METHODS: Forty-seven healthy volunteers, age 21-81 years, were subject at 3T to three-point Dixon fat-fraction measurement, T₁-relaxometry, T₂-relaxometry and magnetisation transfer ratio (MTR) imaging at mid-thigh and mid-calf level bilaterally. Fifteen subjects underwent repeat imaging at 2 weeks. RESULTS: Mean between-muscle fat fraction and T₂ differences were small, but significant (p < 0.001). Fat fraction and T 2 correlated positively, and MTR negatively with subject age in both the thigh and calf, with similar significant correlations with weight at thigh level only (p < 0.001 to p < 0.05). Scan-rescan and inter-observer intra-class correlation coefficients ranged between 0.62-0.84 and 0.79-0.99 respectively. CONCLUSIONS: Quantitative lower-limb muscle MRI using readily implementable methods was sensitive enough to demonstrate inter-muscle differences (small in health), and correlations with subject age and weight. In combination with high reliability, this strongly supports the suitability of these methods to provide longitudinal outcome measures in neuromuscular disease treatment trials. KEY POINTS: • Quantitative lower limb muscle MRI provides potential outcome measures in neuromuscular diseases • Bilateral thigh/calf coverage using sequences sensitive to acute and chronic pathology • Measurements have excellent scan-rescan and interobserver reliability • Measurements show small but significant inter-subject age and weight dependency • Readily implementable sequences suitable for further assessment in patient studies.
OBJECTIVES: Quantitative magnetic resonance imaging (MRI) can potentially meet the pressing need for objective, sensitive, reproducible outcome measures in neuromuscular disease trials. We tested, in healthy volunteers, the consistency, reliability and sensitivity to normal inter-subject variation of MRI methods targeted to lower limb muscle pathology to inform the design of practical but comprehensive MRI outcome measure protocols for use in imminent patient studies. METHODS: Forty-seven healthy volunteers, age 21-81 years, were subject at 3T to three-point Dixon fat-fraction measurement, T₁-relaxometry, T₂-relaxometry and magnetisation transfer ratio (MTR) imaging at mid-thigh and mid-calf level bilaterally. Fifteen subjects underwent repeat imaging at 2 weeks. RESULTS: Mean between-muscle fat fraction and T₂ differences were small, but significant (p < 0.001). Fat fraction and T 2 correlated positively, and MTR negatively with subject age in both the thigh and calf, with similar significant correlations with weight at thigh level only (p < 0.001 to p < 0.05). Scan-rescan and inter-observer intra-class correlation coefficients ranged between 0.62-0.84 and 0.79-0.99 respectively. CONCLUSIONS: Quantitative lower-limb muscle MRI using readily implementable methods was sensitive enough to demonstrate inter-muscle differences (small in health), and correlations with subject age and weight. In combination with high reliability, this strongly supports the suitability of these methods to provide longitudinal outcome measures in neuromuscular disease treatment trials. KEY POINTS: • Quantitative lower limb muscle MRI provides potential outcome measures in neuromuscular diseases • Bilateral thigh/calf coverage using sequences sensitive to acute and chronic pathology • Measurements have excellent scan-rescan and interobserver reliability • Measurements show small but significant inter-subject age and weight dependency • Readily implementable sequences suitable for further assessment in patient studies.
Authors: Monika Gloor; Susanne Fasler; Arne Fischmann; Tanja Haas; Oliver Bieri; Karl Heinimann; Stephan G Wetzel; Klaus Scheffler; Dirk Fischer Journal: J Magn Reson Imaging Date: 2011-01 Impact factor: 4.813
Authors: Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig Journal: Neuroimage Date: 2006-03-20 Impact factor: 6.556
Authors: Hermien E Kan; Tom W J Scheenen; Marielle Wohlgemuth; Dennis W J Klomp; Ivonne van Loosbroek-Wagenmans; George W Padberg; Arend Heerschap Journal: Neuromuscul Disord Date: 2009-03-28 Impact factor: 4.296
Authors: Arne Fischmann; Jasper M Morrow; Christopher D J Sinclair; Mary M Reilly; Michael G Hanna; Tarek Yousry; John S Thornton Journal: J Magn Reson Imaging Date: 2013-10-07 Impact factor: 4.813
Authors: Davide Pareyson; Mary M Reilly; Angelo Schenone; Gian Maria Fabrizi; Tiziana Cavallaro; Lucio Santoro; Giuseppe Vita; Aldo Quattrone; Luca Padua; Franco Gemignani; Francesco Visioli; Matilde Laurà; Davide Radice; Daniela Calabrese; Richard A C Hughes; Alessandra Solari Journal: Lancet Neurol Date: 2011-04 Impact factor: 44.182
Authors: Ke Li; Richard D Dortch; E Brian Welch; Nathan D Bryant; Amanda K W Buck; Theodore F Towse; Daniel F Gochberg; Mark D Does; Bruce M Damon; Jane H Park Journal: NMR Biomed Date: 2014-07-26 Impact factor: 4.044
Authors: Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets Journal: J Neuromuscul Dis Date: 2016-03-03
Authors: Benjamin Leporq; Arnaud Le Troter; Yann Le Fur; Emmanuelle Salort-Campana; Maxime Guye; Olivier Beuf; Shahram Attarian; David Bendahan Journal: MAGMA Date: 2017-03-22 Impact factor: 2.310
Authors: Matthew Farrow; Andrew J Grainger; Ai Lyn Tan; Maya H Buch; Paul Emery; John P Ridgway; Thorsten Feiweier; Steven F Tanner; John Biglands Journal: Br J Radiol Date: 2019-07-12 Impact factor: 3.039
Authors: Alex F Goodall; David A Broadbent; Raluca B Dumitru; David L Buckley; Ai Lyn Tan; Maya H Buch; John D Biglands Journal: Br J Radiol Date: 2020-05-11 Impact factor: 3.039
Authors: Hongge Wang; Matthew Davison; Kathryn Wang; Tai-He Xia; Katherine M Call; Jun Luo; Xingyao Wu; Riccardo Zuccarino; Alexa Bacha; Yunhong Bai; Laurie Gutmann; Shawna M E Feely; Tiffany Grider; Alexander M Rossor; Mary M Reilly; Michael E Shy; John Svaren Journal: Neurology Date: 2021-05-24 Impact factor: 11.800
Authors: Chia-Ying Liu; Jianhua Yao; William C Kovacs; Joseph A Shrader; Galen Joe; Ronald Ouwerkerk; Ami K Mankodi; William A Gahl; Ronald M Summers; Nuria Carrillo Journal: Neurology Date: 2020-11-20 Impact factor: 9.910
Authors: Jasper M Morrow; Christopher D J Sinclair; Arne Fischmann; Pedro M Machado; Mary M Reilly; Tarek A Yousry; John S Thornton; Michael G Hanna Journal: Lancet Neurol Date: 2015-11-06 Impact factor: 44.182